Kumashiro R - Search Results

1

Timing of interferon therapy and sources of infection in patients with acute hepatitis C.

Ogata K, Ide T, Kumashiro R, Kumada H, Yotsuyanagi H, Okita K, Akahane Y, Kaneko S, Tsubouchi H, Tanaka E, Moriwaki H, Nishiguchi S, Kakumu S, Mizokami M, Iino S, Sata M. Ogata K, et al. Among authors: kumashiro r. Hepatol Res. 2006 Jan;34(1):35-40. doi: 10.1016/j.hepres.2005.08.012. Epub 2005 Dec 15. Hepatol Res. 2006. PMID: 16359917

2

Interferon-gamma brings additive anti-viral environment when combined with interferon-alpha in patients with chronic hepatitis C.

Kumashiro R, Ide T, Sasaki M, Murashima S, Suzuki H, Hino T, Morita Y, Miyajima I, Ogata K, Tanaka E, Yoshida H, Tanikawa K, Sata M. Kumashiro R, et al. Hepatol Res. 2002 Jan;22(1):20-26. doi: 10.1016/s1386-6346(01)00113-9. Hepatol Res. 2002. PMID: 11804830

3

Short term and two-step interferon therapy for chronic hepatitis C patients with low HCV RNA levels.

Ide T, Kumashiro R, Hino T, Murashima S, Ogata K, Koga Y, Sata M. Ide T, et al. Among authors: kumashiro r. Hepatol Res. 2002 Feb;22(2):145-151. doi: 10.1016/s1386-6346(01)00127-9. Hepatol Res. 2002. PMID: 11818254

4

Second generation amplicor-HCV monitor assay: clinical features and predictors of the response to interferon.

Ide T, Kumashiro R, Toyoda N, Matsuyama K, Miura T, Sata M. Ide T, et al. Among authors: kumashiro r. Hepatol Res. 2000 Nov;18(3):230-238. doi: 10.1016/s1386-6346(00)00069-3. Hepatol Res. 2000. PMID: 11058827

5

Transcription-mediated amplification is more useful in the follow-up of patients with chronic hepatitis B treated with lamivudine.

Ide T, Kumashiro R, Hino T, Murashima S, Ogata K, Koga Y, Sata M. Ide T, et al. Among authors: kumashiro r. Hepatol Res. 2001 Sep;21(1):76-84. doi: 10.1016/s1386-6346(01)00081-x. Hepatol Res. 2001. PMID: 11470630

6

Incidence of Sjögren's syndrome in Japanese patients with hepatitis C virus infection.

Nagao Y, Hanada S, Shishido S, Ide T, Kumashiro R, Ueno T, Sata M. Nagao Y, et al. Among authors: kumashiro r. J Gastroenterol Hepatol. 2003 Mar;18(3):258-66. doi: 10.1046/j.1440-1746.2003.02982.x. J Gastroenterol Hepatol. 2003. PMID: 12603525 Review.

7

A pilot study of eicosapentaenoic acid therapy for ribavirin-related anemia in patients with chronic hepatitis C.

Ide T, Okamura T, Kumashiro R, Koga Y, Hino T, Hisamochi A, Ogata K, Tanaka K, Kuwahara R, Seki R, Sata M. Ide T, et al. Among authors: kumashiro r. Int J Mol Med. 2003 Jun;11(6):729-32. Int J Mol Med. 2003. PMID: 12736713

8

Predictive factors for remission and death in 73 patients with autoimmune hepatitis in Japan.

Hino T, Kumashiro R, Ide T, Koga Y, Ishii K, Tanaka E, Morita Y, Hisamochi A, Murashima S, Tanaka K, Ogata K, Kuwahara R, Sata M; Autoimmune Hepatitis Study Group. Hino T, et al. Among authors: kumashiro r. Int J Mol Med. 2003 Jun;11(6):749-55. Int J Mol Med. 2003. PMID: 12736717

9

Investigation of associating factors in exacerbation of liver damage after chemotherapy in patients with HBV-related HCC.

Nagamatsu H, Kumashiro R, Itano S, Matsugaki S, Sata M. Nagamatsu H, et al. Among authors: kumashiro r. Hepatol Res. 2003 Aug;26(4):293-301. doi: 10.1016/s1386-6346(03)00158-x. Hepatol Res. 2003. PMID: 12963429

10

Association of troglitazone-induced liver injury with mutation of the cytochrome P450 2C19 gene.

Kumashiro R, Kubota T, Koga Y, Tanaka M, Inada C, Kusaba N, Yoshida H, Hisamochi A, Ide T, Tomita Y, Masumoto N, Tanikawa K, Iga T, Sata M. Kumashiro R, et al. Hepatol Res. 2003 Aug;26(4):337-342. doi: 10.1016/s1386-6346(03)00165-7. Hepatol Res. 2003. PMID: 12963435

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

204 results

Search Page

Filters